Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients

Prevalence of Dyslipidaemia and Associated Risk Factors in a Rural Population in South-Western Uganda: A Community Based Survey

(2015) Gershim Asiki et al.   PLoS One

The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population

(2014) Cavin Epie Bekolo et al.   BMC PUBLIC HEALTH

HIV and Metabolic, Body, and Bone Disorders

(2014) Mohammed K. Ali et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settings

(2014) Zulfa Abrahams et al.   AIDS Research and Therapy

First-line Antiretroviral Therapy and Changes in Lipid Levels Over 3 Years Among HIV-Infected Adults in Tanzania

(2013) Enju Liu et al.   CLINICAL INFECTIOUS DISEASES

A randomized clinical trial comparing metabolic parameters after 48 weeks of standard- and low-dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV-infected South African patients

(2013) CN Menezes et al.   HIV MEDICINE

Does first line antiretroviral therapy increase the prevalence of cardiovascular risk factors in Indian patients?: A cross sectional study

(2013) RAB Carey et al.   Journal of Postgraduate Medicine

Cardiometabolic risk factors among HIV patients on antiretroviral therapy

(2013) James N Kiage et al.   Lipids in Health and Disease

Systematic Review of Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat Gain, Is an Antiretroviral Adverse Drug Reaction

(2013) Reneé de Waal et al.   PLoS One

Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment

(2012) L.G. Ekali et al.   DIABETES & METABOLISM

Effect of Nonnucleoside Reverse Transcriptase Inhibitor–Based Antiretroviral Therapy on Dysglycemia and Insulin Sensitivity in South African HIV-Infected Patients

(2011) Joel A Dave et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Correlation between HIV disease and lipid metabolism in antiretroviral-naïve HIV-infected patients in Japan

(2011) Fukuko Oka et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Hypertriglyceridemia and Waist Circumference Predict Cardiovascular Risk among HIV Patients: A Cross-Sectional Study

(2011) Peter M. Janiszewski et al.   PLoS One

HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response

(2009) Salim S Abdool Karim et al.   LANCET

Antiretroviral therapy as a cardiovascular disease risk factor: fact or fiction? A review of clinical and surrogate outcome studies

(2009) Nina Friis-Møller et al.   Current Opinion in HIV and AIDS

Global epidemiology of HIV

(2009) Peter H Kilmarx   Current Opinion in HIV and AIDS

Efficacy of Antiretroviral Therapy in Africa: Effect on Immunological and Virological Outcome Measures – A Meta-Analysis

(2008) Rebecca Hammond et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Lipoprotein changes in HIV-infected antiretroviral-naïve individuals after starting antiretroviral therapy: ACTG Study A5152s

(2008) James H. Stein et al.   Journal of Clinical Lipidology

Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa

(2008) Catherine G Sutcliffe et al.   LANCET INFECTIOUS DISEASES